Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and OpportunitiesMajed Ghattas, Mohamad‐Gabriel Alameh, Garima Dwivedi et al.|Vaccines|2021Cited by 227
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccinesXuexiang Han, Michael J. Mitchell, Kendall A. Lundgreen et al.|Nature Nanotechnology|2023Cited by 227